Fudong Fan1, Qing Zhou1, Jun Pan1, Hailong Cao1, Kai Li1, Yunxing Xue1, Min Ge1, Xuan Luo1, Yang Chen1, Dongjin Wang2. 1. Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210008, Nanjing, China. 2. Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210008, Nanjing, China. njglwdj@126.com.
Abstract
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) support may be considered to reduce mortality but survival and clinical outcomes are uncertain after Stanford type A Aortic dissection (TAAD). We analyzed the data of TAAD patients with postoperative ECMO support in our institution to investigate clinical outcomes. METHODS: In this retrospective cohort study, all clinical data of TAAD patients with postoperative ECMO support from January 2013 to October 2019 in our institution were harvested. Cases with redo or incomplete records were excluded. RESULTS: 22 cases were enrolled, 18 male and 4 female. The mean age was52.85±10.91 years. 20 patients underwent VA-ECMO treatment and 2 patients received VV-ECMO support. The support time was92.54±78.71 hours. 9 patients were successfully weaned from ECMO. 30-day in-hospital survival rate was 27.27 % (6/22). The follow-up duration is from 5 to 74 months. The median follow-up time is 35 months. Only four patients were still alive at the end of the follow-up period. CONCLUSIONS: The mortality of TAAD patients with postoperativesevere circulatory and respiratory dysfunctions is high. ECMO would be considered as a valuable contribution to save lives. But more experience needs to be accumulated to improve clinical outcome.
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) support may be considered to reduce mortality but survival and clinical outcomes are uncertain after Stanford type A Aortic dissection (TAAD). We analyzed the data of TAAD patients with postoperative ECMO support in our institution to investigate clinical outcomes. METHODS: In this retrospective cohort study, all clinical data of TAAD patients with postoperative ECMO support from January 2013 to October 2019 in our institution were harvested. Cases with redo or incomplete records were excluded. RESULTS: 22 cases were enrolled, 18 male and 4 female. The mean age was52.85±10.91 years. 20 patients underwent VA-ECMO treatment and 2 patients received VV-ECMO support. The support time was92.54±78.71 hours. 9 patients were successfully weaned from ECMO. 30-day in-hospital survival rate was 27.27 % (6/22). The follow-up duration is from 5 to 74 months. The median follow-up time is 35 months. Only four patients were still alive at the end of the follow-up period. CONCLUSIONS: The mortality of TAAD patients with postoperativesevere circulatory and respiratory dysfunctions is high. ECMO would be considered as a valuable contribution to save lives. But more experience needs to be accumulated to improve clinical outcome.
Entities:
Keywords:
Clinical outcome; Extracorporeal membrane oxygenation support; Stanford type a aortic dissection
Authors: Giuseppe Maria Raffa; Mariusz Kowalewski; Daniel Brodie; Mark Ogino; Glenn Whitman; Paolo Meani; Michele Pilato; Antonio Arcadipane; Thijs Delnoij; Eshan Natour; Sandro Gelsomino; Jos Maessen; Roberto Lorusso Journal: Ann Thorac Surg Date: 2018-06-28 Impact factor: 4.330
Authors: Maya Guglin; Mark J Zucker; Vanessa M Bazan; Biykem Bozkurt; Aly El Banayosy; Jerry D Estep; John Gurley; Karl Nelson; Rajasekhar Malyala; Gurusher S Panjrath; Joseph B Zwischenberger; Sean P Pinney Journal: J Am Coll Cardiol Date: 2019-02-19 Impact factor: 24.094
Authors: Juan J Russo; Natasha Aleksova; Ian Pitcher; Etienne Couture; Simon Parlow; Mohammad Faraz; Sarah Visintini; Trevor Simard; Pietro Di Santo; Rebecca Mathew; Derek Y So; Koji Takeda; A Reshad Garan; Dimitrios Karmpaliotis; Hiroo Takayama; Ajay J Kirtane; Benjamin Hibbert Journal: J Am Coll Cardiol Date: 2019-02-19 Impact factor: 24.094
Authors: Arturo Evangelista; Eric M Isselbacher; Eduardo Bossone; Thomas G Gleason; Marco Di Eusanio; Udo Sechtem; Marek P Ehrlich; Santi Trimarchi; Alan C Braverman; Truls Myrmel; Kevin M Harris; Stuart Hutchinson; Patrick O'Gara; Toru Suzuki; Christoph A Nienaber; Kim A Eagle Journal: Circulation Date: 2018-04-24 Impact factor: 29.690
Authors: Paolo Meani; Matteo Matteucci; Federica Jiritano; Dario Fina; Francesco Panzeri; Giuseppe M Raffa; Mariusz Kowalewski; Nuccia Morici; Giovanna Viola; Alice Sacco; Fabrizio Oliva; Amal Alyousif; Sam Heuts; Martijn Gilbers; Rick Schreurs; Jos Maessen; Roberto Lorusso Journal: Ann Cardiothorac Surg Date: 2019-01
Authors: Ibrahim Sultan; Andreas Habertheuer; Tyler Wallen; Mary Siki; Wilson Szeto; Joseph E Bavaria; Matthew Williams; Prashanth Vallabhajosyula Journal: J Card Surg Date: 2017-12-07 Impact factor: 1.620